SPI-1005 Trial for Meniere's Disease Evaluates Safety and Efficacy
A clinical trial is underway to assess the safety and efficacy of SPI-1005 in treating Meniere's disease symptoms.
Asset / Drug
Drug and asset intelligence for SPI-1005 with 4 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.